FDA Application
-
NDC Search Results on Active Ingredient: acetaminophen
Click on Active Ingredient to view the label.
Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
---|---|---|---|---|---|
ACETAMINOPHEN | 70010-160-01 | Granules Pharmaceuticals Inc. | ANDA211544 | HUMAN OTC DRUG | ANDA |
ACETAMINOPHEN | 70010-161-01 | Granules Pharmaceuticals Inc. | HUMAN OTC DRUG | Export only | |
ACETAMINOPHEN | 70010-161-05 | Granules Pharmaceuticals Inc. | HUMAN OTC DRUG | Export only | |
ACETAMINOPHEN | 70010-161-10 | Granules Pharmaceuticals Inc. | HUMAN OTC DRUG | Export only | |
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE | 70010-667-01 | Granules Pharmaceuticals Inc. | ANDA211708 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE | 70010-667-05 | Granules Pharmaceuticals Inc. | ANDA211708 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE | 70010-668-01 | Granules Pharmaceuticals Inc. | ANDA211708 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE | 70010-668-05 | Granules Pharmaceuticals Inc. | ANDA211708 | HUMAN PRESCRIPTION DRUG | ANDA |
OXYCODONE HYDROCHLORIDE; ACETAMINOPHEN | 70010-669-01 | Granules Pharmaceuticals Inc. | ANDA211708 | HUMAN PRESCRIPTION DRUG | ANDA |
OXYCODONE HYDROCHLORIDE; ACETAMINOPHEN | 70010-669-05 | Granules Pharmaceuticals Inc. | ANDA211708 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE | 70010-670-01 | Granules Pharmaceuticals Inc. | ANDA211708 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE | 70010-670-05 | Granules Pharmaceuticals Inc. | ANDA211708 | HUMAN PRESCRIPTION DRUG | ANDA |
HYDROCODONE BITARTRATE; ACETAMINOPHEN | 70010-672-01 | Granules Pharmaceuticals Inc. | ANDA211729 | HUMAN PRESCRIPTION DRUG | ANDA |
HYDROCODONE BITARTRATE; ACETAMINOPHEN | 70010-672-05 | Granules Pharmaceuticals Inc. | ANDA211729 | HUMAN PRESCRIPTION DRUG | ANDA |
HYDROCODONE BITARTRATE; ACETAMINOPHEN | 70010-673-01 | Granules Pharmaceuticals Inc. | ANDA211729 | HUMAN PRESCRIPTION DRUG | ANDA |
HYDROCODONE BITARTRATE; ACETAMINOPHEN | 70010-673-05 | Granules Pharmaceuticals Inc. | ANDA211729 | HUMAN PRESCRIPTION DRUG | ANDA |
HYDROCODONE BITARTRATE; ACETAMINOPHEN | 70010-674-01 | Granules Pharmaceuticals Inc. | ANDA211729 | HUMAN PRESCRIPTION DRUG | ANDA |
HYDROCODONE BITARTRATE; ACETAMINOPHEN | 70010-674-05 | Granules Pharmaceuticals Inc. | ANDA211729 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; IBUPROFEN | 70038-131-36 | RAONBIO CORP | ANDA216592 | HUMAN OTC DRUG | ANDA |
ACETAMINOPHEN; IBUPROFEN | 70038-131-72 | RAONBIO CORP | ANDA216592 | HUMAN OTC DRUG | ANDA |
ACETAMINOPHEN; IBUPROFEN | 70038-131-81 | RAONBIO CORP | ANDA216592 | HUMAN OTC DRUG | ANDA |
ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE; GUAIFENESIN | 70242-102-06 | Dannso Corp./d.b.a. Essential Products | part341 | HUMAN OTC DRUG | OTC monograph final |
DIPHENHYDRAMINE HYDROCHLORIDE; ACETAMINOPHEN | 70253-229-50 | OUR FAMILY (Nash Finch Company) | part338 | HUMAN OTC DRUG | OTC MONOGRAPH FINAL |
DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE; ACETAMINOPHEN | 70253-470-16 | OUR FAMILY (Nash Finch Company) | part341 | HUMAN OTC DRUG | OTC MONOGRAPH FINAL |
ACETAMINOPHEN; PYRILAMINE MALEATE; CAFFEINE | 70262-303-25 | Your Safety Company | part343 | HUMAN OTC DRUG | OTC MONOGRAPH NOT FINAL |
PYRILAMINE MALEATE; ACETAMINOPHEN; CAFFEINE | 70264-012-01 | R J General Corporation | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE; ACETAMINOPHEN | 70264-016-01 | R J General Corporation | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE; GUAIFENESIN | 70264-025-02 | R J General Corporation | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
GUAIFENESIN; ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE | 70264-026-02 | R J General Corporation | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN | 70264-027-01 | R J General Corporation | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
-